Abstract: Poster Presentations |

Smoking Cessation in COPD Patients With Newly Diagnosed Airflow Limitation: A Real Life Approach FREE TO VIEW

Dorota M. Gorecka, MD; Michal Bednarek, MD; Elzbieta Puscinska, MD; Adam Nowinski, MD; Anna Goljan, MD; Jan Zielinski, MD
Author and Funding Information

Institute of TB & Lung Diseases, Warsaw, Poland


Chest. 2003;124(4_MeetingAbstracts):230S-b-231S. doi:10.1378/chest.124.4_MeetingAbstracts.230S-b
Text Size: A A A
Published online


PURPOSE:  To evaluate the effects of smoking intervention in a group of subjects with newly diagnosed airflow limitation (AL).

METHODS:  Of 558 current smokers participating in population spirometric screening for COPD combined with smoking cessation advice, 297 were diagnosed to have AL (FEV1/FVC <0.7). After one year 193 presented for the follow-up visit. Thirty subjects (10.1%) quit smoking. Remaining 163 smokers were invited to the smokers’ clinic. Attendees were randomised to treatment with nicotine patch (n=38) or bupropion SR (n=32). Follow-up was scheduled at 2 weeks (Visit2), end of treatment (Visit3), 6 months (Visit4) and 12 months (Visit5). After 12 months a phone call assessed smoking status. Non-smoking status was validated with carbon monoxide in exhaled air. Patients who did not attend the follow-up visits were considered smokers.

RESULTS:  Of 70 smokers with AL attending smokers’ clinic 40 were males and 30 females, mean (SD) age 56 (10) yrs, age at starting smoking 18 (4) yrs, FEV1 73 (17) %pred, Fagerstrom score 6.5 (2.1), exposed to 43 (18) packyrs. Number (%) of smokers attending follow-up were 57 (81%) at Visit2, 34 (49%) at Visit3, 14 (20%) at Visit4 and 69 (99%) after a year (Visit5). The validated quit rate after 12 months was 18.5% (13/70), 25% in the group treated with bupropion SR and 13% in the group treated with nicotine patch (NS).CONCLUSIONS: In smokers with newly diagnosed COPD, who did not quit smoking as the result of minimal intervention, one year validated cessation rate after pharmacological treatment. was 18.5%. The drop-out rate in the follow-up was considerable, necessitating a phone call after one year to assess the smoking status.CLINICAL IMPLICATIONS : In smokers with newly diagnosed COPD a real life smoking interventions result in considerable one year validated quit rate (10.1% after minimal intervention and 18.5% after pharmacological treatment). Every effort should be applied to increase motivation to quit and participation in the programme of smokers with AL.

DISCLOSURE:  D.M. Gorecka, None.

Wednesday, October 29, 2003

12:30 PM - 2:00 PM




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543